Development of a Patient-Reported Outcome (PRO) Measure to Assess Emotional Impact of Treatment for Type 2 Diabetes.

Kristina S BoyeKatie D StewartLouis S Matza

Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2023)

The EIDTQ-Status and Comparison measures can be used as a supplement to clinical outcomes, such as hemoglobin A1c (HbA1c) and body weight, to provide a broader picture of the patient's emotional experience with medication treatment for T2D.

Keyphrases

type diabetes
body weight
patient reported outcomes
healthcare
cardiovascular disease
emergency department
replacement therapy
red blood cell
combination therapy
weight loss
adverse drug
drug induced